论文信息 - Propylthiouracil Induced Vasculitis : A Rare Adverse Event - 字舞流文

Propylthiouracil Induced Vasculitis : A Rare Adverse Event

[1] F. Azizi. The safety and efficacy of antithyroid drugs , 2006, Expert opinion on drug safety.

[2] J. Franklyn,et al. Propylthiouracil and carbimazole associated‐antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves’ disease , 2004, Clinical endocrinology.

[3] J. Lazarus,et al. PROPYLTHIOURACIL INDUCED ANCA POSITIVE VASCULITIS: A CASE REPORT , 2004 .

[4] K. Ashizawa,et al. Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving anti-thyroid medication. , 2003, Internal medicine.

[5] N. Sera,et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. , 2000, Thyroid : official journal of the American Thyroid Association.

[6] I. Khurshid,et al. Disseminated intravascular coagulation and vasculitis during propylthiouracil therapy , 2000, Postgraduate medical journal.

[7] W. Tyler,et al. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. , 1980, JAMA.

[8] H. Ye,et al. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic autoantibody-associated vasculitis , 2008 .

[9] O. Fain,et al. Systemic Adverse Effect of Antithyroid Drugs , 1999, Clinical Rheumatology.